In 2024, the biotech industry will witness significant advancements, with AI playing a larger role in pharmaceutical processes. Through AI, more complex and sophisticated RNA technologies such as mRNAs, miRNAs, and siRNAs will be developed for immunotherapy and disease treatment. Bioprinting technology and tissue engineering are expected to revolutionize organ transplantation, while stem cell technologies aim to advance treatment for chronic diseases. The growing targeted protein degradation market is projected to accelerate drug discovery, while merger and acquisition activity will shape the industry.
Social Security's insolvency is No. 1 issue, says Sen. Bill Cassidy
Outgoing Sen. Bill Cassidy (R-La.) said Sunday he is “working” on gaining consensus for his proposed reforms to Social Security, which he warns is growing
